Logo for Edgewise Therapeutics Inc

Edgewise Therapeutics Investor Relations Material

Latest events

Logo for Edgewise Therapeutics Inc

Study Result

Edgewise Therapeutics
Logo for Edgewise Therapeutics

Study Result

2 Apr, 2025
Logo for Edgewise Therapeutics

Q4 2024

3 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Edgewise Therapeutics Inc

Access all reports
Edgewise Therapeutics Inc. (EWTX) is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for severe, rare muscle disorders, addressing significant unmet medical needs. Utilizing its proprietary drug discovery platform, Edgewise focuses on targeting the muscle as an organ, combining expertise in muscle biology and small molecule engineering. This approach allows the identification of precision medicines regulating key proteins in muscle tissue. Edgewise Therapeutics is headquartered in Boulder, Colorado, and its shares are listed on the Nasdaq.